{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:26:16Z","timestamp":1791523576607,"version":"4.3.4"},"reference-count":62,"publisher":"Japanese Society of Toxicology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Toxicol. Sci."],"published-print":{"date-parts":[[2024]]},"DOI":"10.2131\/jts.49.175","type":"journal-article","created":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T22:14:42Z","timestamp":1711923282000},"page":"175-191","source":"Crossref","is-referenced-by-count":12,"title":["Reversible and monitorable nephrotoxicity in rats by the novel potent transcriptional enhanced associate domain (TEAD) inhibitor, K-975"],"prefix":"10.2131","volume":"49","author":[{"given":"Hironori","family":"Otsuki","sequence":"first","affiliation":[{"name":"Toxicological Research Laboratories, Research Unit, Research Division, Kyowa Kirin Co., Ltd."},{"name":"Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Uemori","sequence":"additional","affiliation":[{"name":"Toxicological Research Laboratories, Research Unit, Research Division, Kyowa Kirin Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Inai","sequence":"additional","affiliation":[{"name":"Toxicological Research Laboratories, Research Unit, Research Division, Kyowa Kirin Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Toxicological Research Laboratories, Research Unit, Research Division, Kyowa Kirin Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Araki","sequence":"additional","affiliation":[{"name":"Toxicological Research Laboratories, Research Unit, Research Division, Kyowa Kirin Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Nan-ya","sequence":"additional","affiliation":[{"name":"Toxicological Research Laboratories, Research Unit, Research Division, Kyowa Kirin Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouichi","family":"Yoshinari","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Toxicology, School of Pharmaceutical Sciences, University of Shizuoka"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"898","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Abe, T., Shizu, R., Sasaki, T., Shimizu, Y., Hosaka, T., Kodama, S., Matsuzawa, A. and Yoshinari, K. (2019): Functional interaction between pregnane X receptor and yes-associated protein in xenobiotic-dependent liver hypertrophy and drug metabolism. J. Pharmacol. Exp. Ther., <b>371<\/b>, 590-601.","DOI":"10.1124\/jpet.119.258632"},{"key":"2","doi-asserted-by":"publisher","unstructured":"Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin, S., Frasson, C., Basso, G., Guzzardo, V., Fassina, A., Cordenonsi, M. and Piccolo, S. (2014): YAP\/TAZ incorporation in the \u03b2-catenin destruction complex orchestrates the Wnt response. Cell, <b>158<\/b>, 157-170. Elsevier.","DOI":"10.1016\/j.cell.2014.06.013"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Camargo, F.D., Gokhale, S., Johnnidis, J.B., Fu, D., Bell, G.W., Jaenisch, R. and Brummelkamp, T.R. (2007): YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol., <b>17<\/b>, 2054-2060.","DOI":"10.1016\/j.cub.2007.10.039"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Chan, P., Han, X., Zheng, B., DeRan, M., Yu, J., Jarugumilli, G.K., Deng, H., Pan, D., Luo, X. and Wu, X. (2016): Autopalmitoylation of TEAD proteins regulates transcriptional output of the Hippo pathway. Nat. Chem. Biol., <b>12<\/b>, 282-289.","DOI":"10.1038\/nchembio.2036"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Chen, J., Wang, X., He, Q. and Harris, R.C. (2022): TAZ is important for maintenance of the integrity of podocytes. Am. J. Physiol. Renal Physiol., <b>322<\/b>, F419-F428.","DOI":"10.1152\/ajprenal.00426.2021"},{"key":"6","doi-asserted-by":"crossref","unstructured":"Cunningham, R. and Hansen, C.G. (2022): The Hippo pathway in cancer: YAP\/TAZ and TEAD as therapeutic targets in cancer. Clin. Sci. (Lond.), <b>136<\/b>, 197-222.","DOI":"10.1042\/CS20201474"},{"key":"7","doi-asserted-by":"crossref","unstructured":"Dieterle, F., Perentes, E., Cordier, A., Roth, D.R., Verdes, P., Grenet, O., Pantano, S., Moulin, P., Wahl, D., Mahl, A., End, P., Staedtler, F., Legay, F., Carl, K., Laurie, D., Chibout, S.D., Vonderscher, J. and Maurer, G. (2010): Urinary clusterin, cystatin C, \u03b22-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat. Biotechnol., <b>28<\/b>, 463-469.","DOI":"10.1038\/nbt.1622"},{"key":"8","doi-asserted-by":"publisher","unstructured":"Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., Elvassore, N. and Piccolo, S. (2011): Role of YAP\/TAZ in mechanotransduction. Nature, <b>474<\/b>, 179-183.","DOI":"10.1038\/nature10137"},{"key":"9","doi-asserted-by":"crossref","unstructured":"Fuchs, T.C. and Hewitt, P. (2011): Biomarkers for drug-induced renal damage and nephrotoxicity-an overview for applied toxicology. AAPS J., <b>13<\/b>, 615-631.","DOI":"10.1208\/s12248-011-9301-x"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Fujii, M., Toyoda, T., Nakanishi, H., Yatabe, Y., Sato, A., Matsudaira, Y., Ito, H., Murakami, H., Kondo, Y., Kondo, E., Hida, T., Tsujimura, T., Osada, H. and Sekido, Y. (2012): TGF-\u03b2 synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J. Exp. Med., <b>209<\/b>, 479-494.","DOI":"10.1084\/jem.20111653"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Haskins, J.W., Nguyen, D.X. and Stern, D.F. (2014): Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration. Sci. Signal., <b>7<\/b>, ra116.","DOI":"10.1126\/scisignal.2005770"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Hossain, Z., Ali, S.M., Ko, H.L., Xu, J., Ng, C.P., Guo, K., Qi, Z., Ponniah, S., Hong, W. and Hunziker, W. (2007): Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1. Proc. Natl. Acad. Sci. USA, <b>104<\/b>, 1631-1636.","DOI":"10.1073\/pnas.0605266104"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Itoh, M., Nakadate, K., Horibata, Y., Matsusaka, T., Xu, J., Hunziker, W. and Sugimoto, H. (2014): The structural and functional organization of the podocyte filtration slits is regulated by Tjp1\/ZO-1. PLoS One, <b>9<\/b>, e106621.","DOI":"10.1371\/journal.pone.0106621"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Itoh, M., Nakadate, K., Matsusaka, T., Hunziker, W. and Sugimoto, H. (2018): Effects of the differential expression of ZO-1 and ZO-2 on podocyte structure and function. Genes Cells, <b>23<\/b>, 546-556.","DOI":"10.1111\/gtc.12598"},{"key":"15","doi-asserted-by":"crossref","unstructured":"J\u00e4nne, P.A., Wozniak, A.J., Belani, C.P., Keohan, M.L., Ross, H.J., Polikoff, J.A., Mintzer, D.M., Ye, Z., Monberg, M.J. and Obasaju, C.K.; Pemetrexed expanded access program investigators. (2006): Pemetrexed alone or in combination with cisplatin in previously treated malignant pleural mesothelioma: outcomes from a phase IIIB expanded access program. J. Thorac. Oncol., <b>1<\/b>, 506-512.","DOI":"10.1016\/S1556-0864(15)30351-8"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Justice, R.W., Zilian, O., Woods, D.F., Noll, M. and Bryant, P.J. (1995): The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev., <b>9<\/b>, 534-546.","DOI":"10.1101\/gad.9.5.534"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Kakiuchi-Kiyota, S., Schutten, M.M., Zhong, Y., Crawford, J.J. and Dey, A. (2019): Safety Considerations in the Development of Hippo Pathway Inhibitors in Cancers. Front. Cell Dev. Biol., <b>7<\/b>, 156.","DOI":"10.3389\/fcell.2019.00156"},{"key":"18","unstructured":"Kaneda, A., Seike, T., Danjo, T., Nakajima, T., Otsubo, N., Yamaguchi, D., Tsuji, Y., Hamaguchi, K., Yasunaga, M., Nishiya, Y., Suzuki, M., Saito, J.I., Yatsunami, R., Nakamura, S., Sekido, Y. and Mori, K. (2020): The novel potent TEAD inhibitor, K-975, inhibits YAP1\/TAZ-TEAD protein-protein interactions and exerts an anti-tumor effect on malignant pleural mesothelioma. Am. J. Cancer Res., <b>10<\/b>, 4399-4415."},{"key":"19","doi-asserted-by":"crossref","unstructured":"Kim, Y.H., Goyal, M., Kurnit, D., Wharram, B., Wiggins, J., Holzman, L., Kershaw, D. and Wiggins, R. (2001): Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int., <b>60<\/b>, 957-968.","DOI":"10.1046\/j.1523-1755.2001.060003957.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Lu, L., Li, Y., Kim, S.M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G., Finegold, M.J., Lee, J.S. and Johnson, R.L. (2010): Hippo signaling is a potent <i>in vivo<\/i> growth and tumor suppressor pathway in the mammalian liver. Proc. Natl. Acad. Sci. USA, <b>107<\/b>, 1437-1442.","DOI":"10.1073\/pnas.0911427107"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Lu, L., Finegold, M.J. and Johnson, R.L. (2018): Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Exp. Mol. Med., <b>50<\/b>, e423.","DOI":"10.1038\/emm.2017.205"},{"key":"22","doi-asserted-by":"crossref","unstructured":"Makita, R., Uchijima, Y., Nishiyama, K., Amano, T., Chen, Q., Takeuchi, T., Mitani, A., Nagase, T., Yatomi, Y., Aburatani, H., Nakagawa, O., Small, E.V., Cobo-Stark, P., Igarashi, P., Murakami, M., Tominaga, J., Sato, T., Asano, T., Kurihara, Y. and Kurihara, H. (2008): Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am. J. Physiol. -. Ren. Physiol., <b>294<\/b>, 542-553.","DOI":"10.1152\/ajprenal.00201.2007"},{"key":"23","doi-asserted-by":"crossref","unstructured":"M\u00e5rtensson, J. and Bellomo, R. (2014): The rise and fall of NGAL in acute kidney injury. Blood Purif., <b>37<\/b>, 304-310.","DOI":"10.1159\/000364937"},{"key":"24","doi-asserted-by":"crossref","unstructured":"Matsui, Y. and Lai, Z.C. (2013): Mutual regulation between Hippo signaling and actin cytoskeleton. Protein Cell, <b>4<\/b>, 904-910.","DOI":"10.1007\/s13238-013-3084-z"},{"key":"25","doi-asserted-by":"crossref","unstructured":"McClatchey, A.I., Saotome, I., Mercer, K., Crowley, D., Gusella, J.F., Bronson, R.T. and Jacks, T. (1998): Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors. Genes Dev., <b>12<\/b>, 1121-1133.","DOI":"10.1101\/gad.12.8.1121"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Messmer, K.J. and Abel, S.R. (2001): Verteporfin for age-related macular degeneration. Ann. Pharmacother., <b>35<\/b>, 1593-1598.","DOI":"10.1345\/1542-6270(2001)035<1593:VFARMD>2.0.CO;2"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Moroishi, T., Hansen, C.G. and Guan, K.L. (2015): The emerging roles of YAP and TAZ in cancer. Nat. Rev. Cancer, <b>15<\/b>, 73-79.","DOI":"10.1038\/nrc3876"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Mundel, P. and Reiser, J. (2010): Proteinuria: an enzymatic disease of the podocyte? Kidney Int., <b>77<\/b>, 571-580.","DOI":"10.1038\/ki.2009.424"},{"key":"29","doi-asserted-by":"crossref","unstructured":"Mundel, P., Heid, H.W., Mundel, T.M., Kr\u00fcger, M., Reiser, J. and Kriz, W. (1997): Synaptopodin: an actin-associated protein in telencephalic dendrites and renal podocytes. J. Cell Biol., <b>139<\/b>, 193-204.","DOI":"10.1083\/jcb.139.1.193"},{"key":"30","doi-asserted-by":"crossref","unstructured":"Nan-ya, K., Kajihara, M., Kojima, N. and Degawa, M. (2015): Usefulness of urinary kidney injury molecule-1 (Kim-1) as a biomarker for cisplatin-induced sub-chronic kidney injury. J. Appl. Toxicol., <b>35<\/b>, 124-132.","DOI":"10.1002\/jat.2999"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Nardone, G., Oliver-De La Cruz, J., Vrbsky, J., Martini, C., Pribyl, J., Skl\u00e1dal, P., Pe\u0161l, M., Caluori, G., Pagliari, S., Martino, F., Maceckova, Z., Hajduch, M., Sanz-Garcia, A., Pugno, N.M., Stokin, G.B. and Forte, G. (2017): YAP regulates cell mechanics by controlling focal adhesion assembly. Nat. Commun., <b>8<\/b>, 15321.","DOI":"10.1038\/ncomms15321"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Noland, C.L., Gierke, S., Schnier, P.D., Murray, J., Sandoval, W.N., Sagolla, M., Dey, A., Hannoush, R.N., Fairbrother, W.J. and Cunningham, C.N. (2016): Palmitoylation of TEAD Transcription Factors Is Required for Their Stability and Function in Hippo Pathway Signaling. Structure, <b>24<\/b>, 179-186.","DOI":"10.1016\/j.str.2015.11.005"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Ozer, J.S., Dieterle, F., Troth, S., Perentes, E., Cordier, A., Verdes, P., Staedtler, F., Mahl, A., Grenet, O., Roth, D.R., Wahl, D., Legay, F., Holder, D., Erdos, Z., Vlasakova, K., Jin, H., Yu, Y., Muniappa, N., Forest, T., Clouse, H.K., Reynolds, S., Bailey, W.J., Thudium, D.T., Topper, M.J., Skopek, T.R., Sina, J.F., Glaab, W.E., Vonderscher, J., Maurer, G., Chibout, S.D., Sistare, F.D. and Gerhold, D.L. (2010): A panel of urinary biomarkers to monitor reversibility of renal injury and a serum marker with improved potential to assess renal function. Nat. Biotechnol., <b>28<\/b>, 486-494.","DOI":"10.1038\/nbt.1627"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Park, J. and Hansen, C.G. (2021): Cellular feedback dynamics and multilevel regulation driven by the hippo pathway. Biochem. Soc. Trans., <b>49<\/b>, 1515-1527.","DOI":"10.1042\/BST20200253"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Pavenst\u00e4dt, H., Kriz, W. and Kretzler, M. (2003): Cell biology of the glomerular podocyte. Physiol. Rev., <b>83<\/b>, 253-307.","DOI":"10.1152\/physrev.00020.2002"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Pei, T., Li, Y., Wang, J., Wang, H., Liang, Y., Shi, H., Sun, B., Yin, D., Sun, J., Song, R., Pan, S., Sun, Y., Jiang, H., Zheng, T. and Liu, L. (2015): YAP is a critical oncogene in human cholangiocarcinoma. Oncotarget, <b>6<\/b>, 17206-17220.","DOI":"10.18632\/oncotarget.4043"},{"key":"37","doi-asserted-by":"crossref","unstructured":"Pfaller, W. and Gstraunthaler, G. (1998): Nephrotoxicity testing <i>in vitro<\/i>--what we know and what we need to know. Environ. Health Perspect., <b>106<\/b> (Suppl 2), 559-569.","DOI":"10.1289\/ehp.98106559"},{"key":"38","doi-asserted-by":"crossref","unstructured":"Piccolo, S., Dupont, S. and Cordenonsi, M. (2014): The biology of YAP\/TAZ: hippo signaling and beyond. Physiol. Rev., <b>94<\/b>, 1287-1312.","DOI":"10.1152\/physrev.00005.2014"},{"key":"39","doi-asserted-by":"publisher","unstructured":"Prozialeck, W.C., VanDreel, A., Ackerman, C.D., Stock, I., Papaeliou, A., Yasmine, C., Wilson, K., Lamar, P.C., Sears, V.L., Gasiorowski, J.Z., DiNovo, K.M., Vaidya, V.S. and Edwards, J.R. (2016): Evaluation of cystatin C as an early biomarker of cadmium nephrotoxicity in the rat. Biometals, <b>29<\/b>, 131-146.","DOI":"10.1007\/s10534-015-9903-3"},{"key":"40","doi-asserted-by":"crossref","unstructured":"Rausch, V. and Hansen, C.G. (2020): The Hippo Pathway, YAP\/TAZ, and the Plasma Membrane. Trends Cell Biol., <b>30<\/b>, 32-48.","DOI":"10.1016\/j.tcb.2019.10.005"},{"key":"41","doi-asserted-by":"crossref","unstructured":"Reginensi, A., Scott, R.P., Gregorieff, A., Bagherie-Lachidan, M., Chung, C., Lim, D.S., Pawson, T., Wrana, J. and McNeill, H. (2013): Yap- and Cdc42-dependent nephrogenesis and morphogenesis during mouse kidney development. PLoS Genet., <b>9<\/b>, e1003380.","DOI":"10.1371\/journal.pgen.1003380"},{"key":"42","doi-asserted-by":"crossref","unstructured":"Reiser, J. and Altintas, M.M. (2016): Podocytes. F1000 Res., <b>5<\/b>, 1-19.","DOI":"10.12688\/f1000research.7255.1"},{"key":"43","doi-asserted-by":"crossref","unstructured":"Ricardo, S.D., Bertram, J.F. and Ryan, G.B. (1994): Antioxidants protect podocyte foot processes in puromycin aminonucleoside-treated rats. J. Am. Soc. Nephrol., <b>4<\/b>, 1974-1986.","DOI":"10.1681\/ASN.V4121974"},{"key":"44","doi-asserted-by":"publisher","unstructured":"Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J.R., Zhou, D., Kreger, B.T., Vasioukhin, V., Avruch, J., Brummelkamp, T.R. and Camargo, F.D. (2011): Yap1 acts downstream of \u03b1-catenin to control epidermal proliferation. Cell, <b>144<\/b>, 782-795.","DOI":"10.1016\/j.cell.2011.02.031"},{"key":"45","doi-asserted-by":"crossref","unstructured":"Schwartzman, M., Reginensi, A., Wong, J.S., Basgen, J.M., Meliambro, K., Nicholas, S.B., D\u2019Agati, V., McNeill, H. and Campbell, K.N. (2016): Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure. J. Am. Soc. Nephrol., <b>27<\/b>, 216-226.","DOI":"10.1681\/ASN.2014090916"},{"key":"46","doi-asserted-by":"crossref","unstructured":"Scott, R.P. and Quaggin, S.E. (2015): Review series: the cell biology of renal filtration. J. Cell Biol., <b>209<\/b>, 199-210.","DOI":"10.1083\/jcb.201410017"},{"key":"47","doi-asserted-by":"crossref","unstructured":"Song, H., Mak, K.K., Topol, L., Yun, K., Hu, J., Garrett, L., Chen, Y., Park, O., Chang, J., Simpson, R.M., Wang, C.Y., Gao, B., Jiang, J. and Yang, Y. (2010): Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc. Natl. Acad. Sci. USA, <b>107<\/b>, 1431-1436.","DOI":"10.1073\/pnas.0911409107"},{"key":"48","doi-asserted-by":"crossref","unstructured":"Srivastava, T., Garola, R.E., Whiting, J.M. and Alon, U.S. (2001): Synaptopodin expression in idiopathic nephrotic syndrome of childhood. Kidney Int., <b>59<\/b>, 118-125.","DOI":"10.1046\/j.1523-1755.2001.00472.x"},{"key":"49","doi-asserted-by":"crossref","unstructured":"St John, M.A., Tao, W., Fei, X., Fukumoto, R., Carcangiu, M.L., Brownstein, D.G., Parlow, A.F., McGrath, J. and Xu, T. (1999): Mice deficient of Lats1 develop soft-tissue sarcomas, ovarian tumours and pituitary dysfunction. Nat. Genet., <b>21<\/b>, 182-186.","DOI":"10.1038\/5965"},{"key":"50","doi-asserted-by":"crossref","unstructured":"Thakur, V., Walker, P.D. and Shah, S.V. (1988): Evidence suggesting a role for hydroxyl radical in puromycin aminonucleoside-induced proteinuria. Kidney Int., <b>34<\/b>, 494-499.","DOI":"10.1038\/ki.1988.208"},{"key":"51","doi-asserted-by":"crossref","unstructured":"Thielemans, N., Lauwerys, R. and Bernard, A. (1994): Competition between albumin and low-molecular-weight proteins for renal tubular uptake in experimental nephropathies. Nephron J., <b>66<\/b>, 453-458.","DOI":"10.1159\/000187863"},{"key":"52","doi-asserted-by":"crossref","unstructured":"Torregrosa, I., Montoliu, C., Urios, A., Andr\u00e9s-Costa, M.J., Gim\u00e9nez-Garz\u00f3, C., Juan, I., Puchades, M.J., Blasco, M.L., Carratal\u00e1, A., Sanju\u00e1n, R. and Miguel, A. (2015): Urinary KIM-1, NGAL and L-FABP for the diagnosis of AKI in patients with acute coronary syndrome or heart failure undergoing coronary angiography. Heart Vessels, <b>30<\/b>, 703-711.","DOI":"10.1007\/s00380-014-0538-z"},{"key":"53","doi-asserted-by":"crossref","unstructured":"Vaidya, V.S., Ozer, J.S., Dieterle, F., Collings, F.B., Ramirez, V., Troth, S., Muniappa, N., Thudium, D., Gerhold, D., Holder, D.J., Bobadilla, N.A., Marrer, E., Perentes, E., Cordier, A., Vonderscher, J., Maurer, G., Goering, P.L., Sistare, F.D. and Bonventre, J.V. (2010): Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat. Biotechnol., <b>28<\/b>, 478-485.","DOI":"10.1038\/nbt.1623"},{"key":"54","doi-asserted-by":"crossref","unstructured":"Wang, S., Ma, K., Chen, L., Zhu, H., Liang, S., Liu, M. and Xu, N. (2016): TAZ promotes cell growth and inhibits Celastrol-induced cell apoptosis. Biosci. Rep., <b>36<\/b>, 1-10.","DOI":"10.1042\/BSR20160135"},{"key":"55","doi-asserted-by":"crossref","unstructured":"Wang, Y., Wang, Y.P., Tay, Y.C. and Harris, D.C. (2000): Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events. Kidney Int., <b>58<\/b>, 1797-1804.","DOI":"10.1046\/j.1523-1755.2000.00342.x"},{"key":"56","doi-asserted-by":"crossref","unstructured":"Wharram, B.L., Goyal, M., Wiggins, J.E., Sanden, S.K., Hussain, S., Filipiak, W.E., Saunders, T.L., Dysko, R.C., Kohno, K., Holzman, L.B. and Wiggins, R.C. (2005): Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J. Am. Soc. Nephrol., <b>16<\/b>, 2941-2952.","DOI":"10.1681\/ASN.2005010055"},{"key":"57","doi-asserted-by":"crossref","unstructured":"Wong, J.S., Meliambro, K., Ray, J. and Campbell, K.N. (2016): Hippo signaling in the kidney: the good and the bad. Am. J. Physiol. Renal Physiol., <b>311<\/b>, F241-F248.","DOI":"10.1152\/ajprenal.00500.2015"},{"key":"58","doi-asserted-by":"crossref","unstructured":"Wu, M.T., Lam, K.K., Lee, W.C., Hsu, K.T., Wu, C.H., Cheng, B.C., Ng, H.Y., Chi, P.J., Lee, Y.T. and Lee, C.T. (2012): Albuminuria, proteinuria, and urinary albumin to protein ratio in chronic kidney disease. J. Clin. Lab. Anal., <b>26<\/b>, 82-92.","DOI":"10.1002\/jcla.21487"},{"key":"59","doi-asserted-by":"crossref","unstructured":"Xin, M., Kim, Y., Sutherland, L.B., Murakami, M., Qi, X., McAnally, J., Porrello, E.R., Mahmoud, A.I., Tan, W., Shelton, J.M., Richardson, J.A., Sadek, H.A., Bassel-Duby, R. and Olson, E.N. (2013): Hippo pathway effector Yap promotes cardiac regeneration. Proc. Natl. Acad. Sci. USA, <b>110<\/b>, 13839-13844.","DOI":"10.1073\/pnas.1313192110"},{"key":"60","doi-asserted-by":"crossref","unstructured":"Zhang, X., George, J., Deb, S., Degoutin, J.L., Takano, E.A., Fox, S.B., Bowtell, D.D. and Harvey, K.F.; AOCS Study group. (2011): The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene, <b>30<\/b>, 2810-2822.","DOI":"10.1038\/onc.2011.8"},{"key":"61","doi-asserted-by":"publisher","unstructured":"Zhou, D., Conrad, C., Xia, F., Park, J.S., Payer, B., Yin, Y., Lauwers, G.Y., Thasler, W., Lee, J.T., Avruch, J. and Bardeesy, N. (2009): Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell, <b>16<\/b>, 425-438.","DOI":"10.1016\/j.ccr.2009.09.026"},{"key":"62","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Huang, T., Cheng, A.S., Yu, J., Kang, W. and To, K.F. (2016): The TEAD family and its oncogenic role in promoting tumorigenesis. Int. J. Mol. Sci., <b>17<\/b>, 1-15.","DOI":"10.3390\/ijms17010138"}],"container-title":["The Journal of Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/49\/4\/49_175\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,6]],"date-time":"2024-04-06T04:29:33Z","timestamp":1712377773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jts\/49\/4\/49_175\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.2131\/jts.49.175","relation":{},"ISSN":["0388-1350","1880-3989"],"issn-type":[{"value":"0388-1350","type":"print"},{"value":"1880-3989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]}}}